Kanser biyolojisi ve tedavi alan\u0131nda \u00e7\u0131\u011f\u0131r a\u00e7an bir geli\u015fme ya\u015fand\u0131. Boston Children\u2019s Hospital\u2019dan Dr. Ryan Flynn liderli\u011findeki ara\u015ft\u0131rma ekibi, Cambridge Stem Cell Institute i\u015f birli\u011fiyle, h\u00fccre y\u00fczeyinde bulunan yeni bir RNA-ba\u011flay\u0131c\u0131 protein s\u0131n\u0131f\u0131na odakland\u0131. Nature Biotechnology dergisinde yay\u0131mlanan bu \u00e7\u0131\u011f\u0131r a\u00e7an \u00e7al\u0131\u015fma, akut miyeloid l\u00f6semi (AML) ve baz\u0131 solid t\u00fcm\u00f6rlerde malign h\u00fccrelerin y\u00fczeyinde bulunan n\u00fckleofosmin 1 (NPM1) proteininin hedeflenmesine y\u00f6nelik g\u00fc\u00e7l\u00fc bir terapi yakla\u015f\u0131m\u0131 sunuyor. Bu y\u00f6ntem, klasik kanser h\u00fccresi hedefleme paradigmas\u0131n\u0131 k\u00f6kten de\u011fi\u015ftirirken, ayn\u0131 zamanda sa\u011fl\u0131kl\u0131 dokulara zarar vermemeyi ama\u00e7layan umut vadeden bir tedavi olana\u011f\u0131 da do\u011furuyor.<\/p>\n
AML, \u00f6zellikle molek\u00fcler a\u00e7\u0131dan karma\u015f\u0131k yap\u0131s\u0131yla tedavi zorluklar\u0131 yaratan agresif bir kan kanseridir. Malign h\u00fccrelerin yan\u0131 s\u0131ra sa\u011fl\u0131kl\u0131 hematopoetik k\u00f6k h\u00fccrelerde de kritik i\u015flev g\u00f6ren bir\u00e7ok yolak, tedavi se\u00e7ene\u011finin s\u0131n\u0131rlanmas\u0131na neden olmaktad\u0131r. Bu nedenle kullan\u0131lan konvansiyonel ila\u00e7lar, kanser h\u00fccreleri ile sa\u011fl\u0131kl\u0131 h\u00fccreler aras\u0131nda net ayr\u0131m yapamad\u0131\u011f\u0131 i\u00e7in yan etki profilleri a\u011f\u0131r olmakta ve hasta tolerans\u0131 d\u00fc\u015fmektedir. Bu durum, kanser h\u00fccrelerine \u00f6zg\u00fc ve tedaviye hassas yan\u0131t verebilecek se\u00e7ici molek\u00fcler hedeflerin bulunmas\u0131n\u0131 birincil ihtiya\u00e7 haline getirmektedir.<\/p>\n
Flynn ve ekibinin \u00e7al\u0131\u015fmas\u0131nda \u00f6ne \u00e7\u0131kan \u00f6zellik, RNA-ba\u011flay\u0131c\u0131 protein olan NPM1\u2019in AML h\u00fccrelerinin y\u00fczeyinde ectopik (anormal) \u015fekilde bulunmas\u0131d\u0131r. NPM1, normalde \u00e7ekirdek\u00e7ikte ribozom biyogenezinin d\u00fczenlenmesi ve genom stabilitesinde g\u00f6rev yapan bir molek\u00fclken, kanser h\u00fccrelerinin y\u00fczeyinde yo\u011fun olarak eksprese edilmesi beklenmedik bir durumdur. Yap\u0131lan detayl\u0131 analizler, bu protein y\u00fczey ifadesinin sa\u011fl\u0131kl\u0131 k\u00f6k h\u00fccrelerdekinin 100 kat\u0131ndan daha y\u00fcksek oldu\u011funu ortaya koymu\u015ftur. Bu \u00f6nemli ifade fark\u0131, terap\u00f6tik m\u00fcdahale i\u00e7in kusursuz bir hedef sunmaktad\u0131r.<\/p>\n
Bu olgunun molek\u00fcler mekanizmas\u0131, h\u00fccre y\u00fczeyinde bulunan yeni tan\u0131mlanm\u0131\u015f glikoRNA lar\u0131n varl\u0131\u011f\u0131yla ba\u011flant\u0131l\u0131d\u0131r. GlikoRNAs, h\u00fccre d\u0131\u015f y\u00fczeyinde yer alan ve RNA-ba\u011flay\u0131c\u0131 proteinler ile organize kompleksler olu\u015fturan glikokonjuge RNA molek\u00fclleridir. Bu glikoRNA-protein k\u00fcmeleri, h\u00fccrelerin mikro\u00e7evreyle ileti\u015fiminde sinyal platformlar\u0131 olarak i\u015flev g\u00f6rmekte ve h\u00fccre y\u00fczeyi biyolojisi anlay\u0131\u015f\u0131n\u0131 tamamen yeni bir d\u00fczeye ta\u015f\u0131maktad\u0131r. Flynn\u2019\u0131n ekibi, bu molek\u00fcler k\u00fcmelerin \u00f6zelliklerini ayr\u0131nt\u0131l\u0131 bi\u00e7imde ortaya koymu\u015ftur.<\/p>\n
Elde edilen bu \u00f6zg\u00fcn bilgi \u0131\u015f\u0131\u011f\u0131nda, ara\u015ft\u0131rma grubu AML h\u00fccre y\u00fczeyinde bulunan NPM1\u2019i hedef alan monoklonal antikorlar geli\u015ftirmi\u015ftir. Bu antikorlar, preklinik hayvan modellerinde g\u00fc\u00e7l\u00fc anti-l\u00f6kemik etki g\u00f6stermi\u015f ve ayn\u0131 zamanda sa\u011fl\u0131kl\u0131 hematopoetik h\u00fccrelere zarar vermeden yaln\u0131zca hastal\u0131kl\u0131 h\u00fccreleri se\u00e7ici olarak ortadan kald\u0131rm\u0131\u015ft\u0131r. Bu spesifik etki, AML tedavisinde kemik ili\u011fi fonksiyonunun korunmas\u0131 a\u00e7\u0131s\u0131ndan kritik \u00f6neme sahiptir. Ayr\u0131ca, bu antikorlar l\u00f6semi k\u00f6k h\u00fccrelerini de hedefleyebilmekte, bu da hastal\u0131\u011f\u0131n n\u00fcks ve devaml\u0131l\u0131\u011f\u0131ndan sorumlu kritik alt pop\u00fclasyonun ortadan kald\u0131r\u0131lmas\u0131 anlam\u0131na gelmektedir.<\/p>\n
L\u00f6semi k\u00f6k h\u00fccrelerinin tedavide hedeflenmesi b\u00fcy\u00fck bir \u00f6neme sahiptir. Bu h\u00fccreler konvansiyonel kemoterapilere kar\u015f\u0131 diren\u00e7li olup, hastal\u0131\u011f\u0131n tekrarlamas\u0131n\u0131n ba\u015fl\u0131ca sorumlular\u0131 aras\u0131nda yer al\u0131r. Y\u00fczeylerinde bulunan benzersiz NPM1 antigeni sayesinde do\u011frudan sald\u0131r\u0131ya u\u011framalar\u0131, AML\u2019de sadece hastal\u0131\u011f\u0131n kontrol\u00fcnden \u00f6te kal\u0131c\u0131 remisyon veya k\u00fcr \u015fans\u0131n\u0131 g\u00fcndeme getirir. Fare modellerinde bu yakla\u015f\u0131m, ya\u015fam s\u00fcresini anlaml\u0131 bi\u00e7imde uzatm\u0131\u015f ve hastal\u0131k y\u00fck\u00fcn\u00fc azaltm\u0131\u015f, yan etkiler ise g\u00f6zlenmemi\u015ftir. Bu da klinik potansiyelinin olduk\u00e7a g\u00fc\u00e7l\u00fc oldu\u011funu g\u00f6stermektedir.<\/p>\n
Ara\u015ft\u0131rma ekibi, \u00e7al\u0131\u015fmas\u0131n\u0131 sadece AML ile s\u0131n\u0131rland\u0131rmam\u0131\u015f; farkl\u0131 solid t\u00fcm\u00f6rlerdeki NPM1 y\u00fczey ekspresyonunu da incelemi\u015ftir. Toplam 47 insan ve fare solid t\u00fcm\u00f6r modeli \u00fczerinde tarama yap\u0131ld\u0131\u011f\u0131nda, prostat ve kolorektal kanser gibi pek \u00e7ok kanser t\u00fcr\u00fcnde y\u00fczey NPM1\u2019in de\u011fi\u015fken ancak anlaml\u0131 d\u00fczeylerde bulundu\u011fu tespit edilmi\u015ftir. Bu bulgu, NPM1 hedefli antikorlar\u0131n, tedavisi g\u00fc\u00e7 ve diren\u00e7li t\u00fcm\u00f6rlerde de ba\u011f\u0131\u015f\u0131kl\u0131k terapileri alan\u0131nda yeni bir silah olarak kullan\u0131lma potansiyelini ortaya koymaktad\u0131r.<\/p>\n
Solid t\u00fcm\u00f6rlerde se\u00e7ici ve \u00f6zg\u00fcn kanser y\u00fczey belirte\u00e7leri bulmak y\u0131llard\u0131r b\u00fcy\u00fck zorluk yaratm\u0131\u015ft\u0131r. \u00d6zellikle kolorektal kanser gibi t\u00fcrler, sa\u011fl\u0131kl\u0131 doku ile ay\u0131rt edilebilen \u00f6zg\u00fcn hedef eksikli\u011finden dolay\u0131 etkin imm\u00fcnoterapilere diren\u00e7 g\u00f6stermektedir. NPM1\u2019in y\u00fczeyde bulunmas\u0131, imm\u00fcn sistemin kanser h\u00fccrelerini tan\u0131y\u0131p yok etmesini sa\u011flayan molek\u00fcler bir \u201ckulplu tutama\u00e7\u201d niteli\u011fi ta\u015f\u0131maktad\u0131r. Bu, \u00e7ok say\u0131da kanser i\u00e7in imm\u00fcnoterapi stratejilerinin yeniden canlanmas\u0131 anlam\u0131na gelmektedir.<\/p>\n
Ara\u015ft\u0131rma, glycoRNA ve RNA-ba\u011flay\u0131c\u0131 proteinlerin t\u00fcm\u00f6rle ili\u015fkili yeni y\u00fczey antigenleri a\u00e7\u0131s\u0131ndan zengin bir kaynak oldu\u011funu ortaya koymaktad\u0131r. Bu molek\u00fcler k\u00fcmelerin h\u00fccre y\u00fczeyinde rastgele de\u011fil, organize bi\u00e7imde yer ald\u0131\u011f\u0131 ve muhtemelen t\u00fcm\u00f6r\u00fcn hayatta kalmas\u0131 ve ba\u011f\u0131\u015f\u0131kl\u0131ktan ka\u00e7\u0131nmas\u0131nda fayda sa\u011flad\u0131\u011f\u0131 d\u00fc\u015f\u00fcn\u00fclmektedir. Ekibin \u00f6n\u00fcm\u00fczdeki \u00e7al\u0131\u015fmalar\u0131nda bu d\u0131\u015fsal lokalizasyonun biyolojik nedenleri \u00e7\u00f6z\u00fclecek ve k\u00fcmedeki di\u011fer hedef ve biyobelirte\u00e7 adaylar\u0131 belirlenecektir.<\/p>\n
Malign h\u00fccrelerin, genellikle h\u00fccre i\u00e7i g\u00f6rev yapan bir RNA-ba\u011flay\u0131c\u0131 protein olan NPM1\u2019i y\u00fczeye ta\u015f\u0131mas\u0131, t\u00fcm\u00f6r\u00fcn h\u00fccre i\u00e7i sinyalizasyon, adezyon veya ba\u011f\u0131\u015f\u0131kl\u0131k mod\u00fclasyonu gibi fonksiyonlar\u0131 de\u011fi\u015ftirmek i\u00e7in geli\u015ftirdi\u011fi yeni bir strateji olarak de\u011ferlendirilmektedir. Bu dinamiklerin b\u00fct\u00fcn\u00fcyle anla\u015f\u0131lmas\u0131, antikor temelli terapilerin iyile\u015ftirilmesi ve h\u00fccresel terapiler veya imm\u00fcn kontrol noktas\u0131 inhibit\u00f6rleri gibi di\u011fer tedavi modaliteleriyle entegrasyonu a\u00e7\u0131s\u0131ndan kritik \u00f6nem ta\u015f\u0131maktad\u0131r.<\/p>\n
Temel bulgular\u0131 klinik d\u00f6n\u00fc\u015f\u00fcme ta\u015f\u0131mak \u00fczere Boston Children\u2019s Hospital, ulusal ve uluslararas\u0131 d\u00fczeyde fikri m\u00fclkiyet haklar\u0131n\u0131 al\u0131narak, NPM1 hedefli antikor terapilerinin geli\u015ftirilmesine zemin haz\u0131rlam\u0131\u015ft\u0131r. Bu da net bir \u015fekilde erken klinik \u00e7al\u0131\u015fmalar\u0131n yak\u0131nda ba\u015flamas\u0131n\u0131n m\u00fcmk\u00fcn oldu\u011funa i\u015faret etmektedir; b\u00f6ylece agresif hematolojik ve solid malignitelere kar\u015f\u0131 yeni bir umut yolu a\u00e7\u0131lacakt\u0131r.<\/p>\n
Molek\u00fcler biyoloji, onkoloji, imm\u00fcnoterapi ve yap\u0131sal biyokimya alanlar\u0131n\u0131 kapsayan disiplinler aras\u0131 bu i\u015f birli\u011fi, yeni terap\u00f6tik hedeflerin ke\u015ffinde bilimsel ortakl\u0131klar\u0131n g\u00fcc\u00fcn\u00fc g\u00f6stermektedir. GlycoRNA biyolojisi, k\u00f6k h\u00fccre ara\u015ft\u0131rmalar\u0131 ve antikor m\u00fchendisli\u011fi alanlar\u0131ndaki uzmanl\u0131klar\u0131n birle\u015fimi, t\u0131bb\u0131n \u00e7\u00f6z\u00fcms\u00fcz sorunlar\u0131na modern ve yenilik\u00e7i \u00e7\u00f6z\u00fcmler sunulmas\u0131n\u0131n \u00f6rne\u011fini te\u015fkil etmektedir.<\/p>\n
\u00d6zetle, Dr. Ryan Flynn ve ekibi, kanser biyolojisinin b\u00fcy\u00fcleyici bir y\u00f6n\u00fcn\u00fc ortaya \u00e7\u0131karm\u0131\u015f; h\u00fccre i\u00e7i RNA-ba\u011flay\u0131c\u0131 bir proteinin anormal y\u00fczey ekspresyonunu terap\u00f6tik bir hedef haline getirmi\u015ftir. Kanser k\u00f6k h\u00fccrelerine y\u00f6nelik hedeflenen spesifik tedavi stratejisi, yan etkileri minimize ederek hastalar i\u00e7in daha g\u00fcvenli ve etkili yeni nesil kanser tedavilerinin yolunu a\u00e7maktad\u0131r. Mekanizmalar\u0131n ve klinik uygulanabilirli\u011fin derinlemesine incelenmesiyle, bu bulgunun AML ve di\u011fer zorlu kanserlerle m\u00fccadelede d\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc bir potansiyeli bulunmaktad\u0131r.<\/p>\n
—<\/p>\n
Ara\u015ft\u0131rma Konusu<\/strong>: Akut miyeloid l\u00f6semi ve solid t\u00fcm\u00f6rlerde h\u00fccre y\u00fczeyindeki RNA-ba\u011flay\u0131c\u0131 protein NPM1\u2019in hedeflenmesiyle tedavi stratejilerinin geli\u015ftirilmesi.<\/p>\n Makale Ba\u015fl\u0131\u011f\u0131<\/strong>: Treatment of acute myeloid leukemia models by targeting a cell-surface RNA-binding protein<\/p>\n Haberin Yay\u0131n Tarihi<\/strong>: 23 Nisan 2025<\/p>\n Web References<\/strong>: Anahtar Kelimeler<\/strong>: Kanser k\u00f6k h\u00fccreleri, RNA-ba\u011flay\u0131c\u0131 proteinler, Miyeloid l\u00f6semi, Gen hedefleme, Molek\u00fcler hedefler, K\u00f6k h\u00fccre terapisi, Antikor terapisi, Monoklonal antikorlar, H\u00fccre y\u00fczey resept\u00f6rleri<\/p>\n","protected":false},"excerpt":{"rendered":" Kanser biyolojisi ve tedavi alan\u0131nda \u00e7\u0131\u011f\u0131r a\u00e7an bir geli\u015fme ya\u015fand\u0131. Boston Children\u2019s Hospital\u2019dan Dr. Ryan Flynn liderli\u011findeki ara\u015ft\u0131rma ekibi, Cambridge Stem Cell Institute i\u015f birli\u011fiyle, h\u00fccre y\u00fczeyinde bulunan yeni bir RNA-ba\u011flay\u0131c\u0131 protein s\u0131n\u0131f\u0131na odakland\u0131. Nature Biotechnology dergisinde yay\u0131mlanan bu \u00e7\u0131\u011f\u0131r a\u00e7an \u00e7al\u0131\u015fma, akut miyeloid l\u00f6semi (AML) ve baz\u0131 solid t\u00fcm\u00f6rlerde malign h\u00fccrelerin y\u00fczeyinde bulunan n\u00fckleofosmin…<\/p>\n","protected":false},"author":1,"featured_media":3617,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[2583,2586,2585,2582,2584],"tmauthors":[],"class_list":{"0":"post-3616","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-akut-miyeloid-losemi-tedavisinde-yeni-hedefler","9":"tag-aml-hucrelerinde-secici-molekuler-tedavi-yaklasimlari","10":"tag-glikorna-protein-kompleksleri-kanser-biyolojisi","11":"tag-kanser-hucre-yuzeyindeki-rna-baglayan-proteinler","12":"tag-npm1-proteini-kanser-tedavisi"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/04\/Kanser-Hucre-Yuzeyindeki-RNA-Baglayan-Proteinler-1745401470.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3616","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=3616"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3616\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/3617"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=3616"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=3616"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=3616"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=3616"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n– DOI: 10.1038\/s41587-025-02648-2
\n– Flynn Lab at Boston Children\u2019s Hospital
\n– Cambridge Stem Cell Institute<\/p>\n